Warning: The NCBI web site requires JavaScript to function. more...
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.
Arthritis Res Ther. 2009;11(5):R156. Epub 2009 Oct 15.
Related citations
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.
Ann Rheum Dis. 2007 Jun;66(6):790-7. Epub 2006 Dec 21.
Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL, Boumediene A, Lalloue F, Gondran G, Loustaud-Ratti V, Vidal E, Jauberteau MO.
Scand J Rheumatol. 2009 Jan-Feb;38(1):50-7.
Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A.
Singapore Med J. 2007 Sep;48(9):847-9.
Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D, DeClerck LS, Bridts CH, Stevens WJ.
In Vivo. 1994 Jul-Aug;8(4):577-80.
Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G.
J Rheumatol. 2009 Oct;36(10):2190-4. Epub 2009 Sep 15.
Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG.
J Autoimmun. 2006 May;26(3):165-71. Epub 2006 Apr 18.
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE, Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT.
Ann Rheum Dis. 2010 Jul;69(7):1378-82. Epub 2009 Nov 16.
Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, Pérez C, Sáez C, Panes O, Matus V, Mezzano D.
Thromb Haemost. 2006 Jan;95(1):94-9.
Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.
Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RS, Wilson PB.
Clin Exp Immunol. 1992 Sep;89(3):452-5.
Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.
Bartoloni E, Ludovini V, Alunno A, Pistola L, Bistoni O, Crinò L, Gerli R.
Lupus. 2011 Aug;20(9):928-35. Epub 2011 May 25.
Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
Kovács L, Marczinovits I, György A, Tóth GK, Dorgai L, Pál J, Molnár J, Pokorny G.
Rheumatology (Oxford). 2005 Aug;44(8):1021-5. Epub 2005 May 11.
Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, Cayuela JM, Sibilia J, Mariette X.
Ann Rheum Dis. 2007 Jan;66(1):23-7. Epub 2006 Mar 28.
Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis.
Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ.
Br J Haematol. 2001 Nov;115(2):451-9.
[The application of combined detection of autoantibodies in primary Sjögren's syndrome].
He J, Fang W, Li ZG.
Zhonghua Nei Ke Za Zhi. 2008 May;47(5):366-8. Chinese.
Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A, Rinaldi T, Riccieri V, Taccari E, Valesini G.
Clin Exp Rheumatol. 2002 Mar-Apr;20(2):213-6.
Is there a link between inflammation and abnormal lipoprotein profile in Sjögren's syndrome?
Cruz W, Fialho S, Morato E, Castro G, Zimmermann A, Ribeiro G, Neves F, Pereira I.
Joint Bone Spine. 2010 May;77(3):229-31. Epub 2010 Apr 7.
BAFF overexpression is associated with autoantibody production in autoimmune diseases.
Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, Youinou P.
Ann N Y Acad Sci. 2005 Jun;1050:34-9.
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
Markeljević J, Batinić D, Uzarević B, Bozikov J, Cikes N, Babić-Naglić D, Horvat Z, Marusić M.
J Rheumatol. 1994 Dec;21(12):2225-30.
Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases.
Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M.
Clin Rheumatol. 1999;18(1):28-32.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on